The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / E••••• R•••

R•• I••• G•••• Invests in E••••• R••• to Expand Capabilities for Venture-Backed Life Science Companies

Growth investmentannouncedannounced May 20, 2026Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Founder
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • B•• B•••••••Deal partnerconfirmed
    "E••••• R••• is a recognized standard-setter in life sciences finance and accounting, which is among the most demanding sectors for financial professionals," said B•• B•••••••, Co-Chief Executive Officer of R•• I••• G••••.
  • R•• I••• G••••, a Menlo Park-based private investment firm, today announced a strategic growth investment in E••••• R•••, a finance and accounting partner for venture-backed life science companies.
Side not stated
  • M••• R•••Managementconfirmed
    This investment will allow us to expand our team, deepen our capabilities and continue investing in systems that help our clients reach critical milestones — while preserving our proven approach and unique culture," said M••• R•••, Co-Founder and Chief Executive Officer of E••••• R•••.
  • R•• I••• G••••, a Menlo Park-based private investment firm, today announced a strategic growth investment in E••••• R•••, a finance and accounting partner for venture-backed life science companies.
Evidence
R•• I••• G••••, a Menlo Park-based private investment firm, today announced a strategic growth investment in E••••• R•••, a finance and accounting partner for venture-backed life science companies.
R•• I••• G•••• Invests in E••••• R••• to Expand Capabilities for Venture-Backed Life Scien | Private Equity Intelligence | DFX